Sequential re-rating: management describes the same offering landing bigger the second and third time around
The model's full reasoning — Q1 2024 call → NOWe need to determine if management describes successive engagements of the same kind coming in at progressively larger size. Look for comparisons against own past, real and recurring, early stage. Transcript: Zvi discusses growth strategies. He mentions "more types of transactions", "covering more aspects", "more buyer seller interactions", "data and connectivity". He talks about United Airlines partnership: "United Airlines has chosen Freightos as their main technology partner to build a state-of-the-art air cargo web portal." This is a broader engagement than typical? He says: "So it's actually, you know, what we're doing for most of the other airlines is that we're a platform that connects to them, but not we're not building their portal. So if you go to the website of, you know, whatever Lufthansa or, Air France KLM, then we're not involved in that. You're talking to them directly, and we're not involved in building their own, private portals. If you come to our WebCargo by Freightos, then, of course, you can communicate with all the airlines, through us, and that goes through us. But for United, we're actually, being trusted as their partner to build their own portal, which means that all bookings, on United, whether you go to their own website, whether you come even through one of the small third-party platforms, we're actually there providing the technology for all their channels effectively." This indicates a larger scope for United than typical airline engagements. But is this a pattern of escalating size? He says "we have a strong pipeline of new airlines for the second quarter" but doesn't say they are larger. He also mentions "we expanded our carrier base to 49 carrier sellers" and "multiple carrier rollouts". But no explicit comparison of deal size over time. He mentions "carrier cohort analysis on the right indicates dramatic growth in bookings for each new carrier soon after joining" - that's about bookings growth, not deal size. He also mentions "we started dynamically suggesting alternative options" etc. No mention of average deal size increasing.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| SGRY | Surgery Partners, Inc. | Q2 2022 | 2022-08-02 | B+ |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
AKYA · Q2 2023 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing a clear pattern of escalating project sizes in the translational/clinical space. Brian notes a migration from exploratory studies (reasonable size) to larger retrospective studies and even larger retrospective-prospective ongoing clinical studies, with projects moving "further and further downstream.
ASAN · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES Management describes exactly this pattern. Dustin notes the company is “closing larger deals and expanding seats across departments and geographies quickly in large organizations,” and that the growth in the >$50k cohort “reflected an acceleration in our largest enterprise customers.
SGRY · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing exactly this pattern for physician recruiting cohorts. Wayne notes that the 2022 cohorts are “no exception to this trend, bringing more cases with a higher overall net revenue per case than our 2021 cohorts did in the same period last year.